Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab Medical Dialogues Bureau28 Jun 2019 7:00 AM GMTThe initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
Biomunex signs licensing agreement with Sanofi for development of antibodies Medical Dialogues Bureau19 Jan 2019 3:45 AM GMTUnder the terms of the agreement, Sanofi will have access to Biomunex proprietary technology to generate and optimize bi- and multi-specific antibody...